Suresh Vatsyayann
The growth of the market is attributed to the increasing adoption of digital pathology to boost research laboratory potency, rising prevalence of cancer, growing applications of digital pathology in drug development and companion medicine, easy consultation and increasing initiatives by governments and business players. Introduction of affordable scanners for pathology practices, personalised drugs and integration of laboratory info systems (LIS) and digital pathology systems are expected to supply important growth opportunities for makers in the coming years.
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi